Literature DB >> 21448489

Rhenium(IV) compounds inducing apoptosis in cancer cells.

José Martínez-Lillo1, Teresa F Mastropietro, Rosamaria Lappano, Antonio Madeo, Marta E Alberto, Nino Russo, Marcello Maggiolini, Giovanni De Munno.   

Abstract

The anticancer properties of a series of mononuclear Re(IV) compounds of formula ReCl(4)L (where L is bpy = 2,2'-bipyridine; bpym = 2,2'-bipyrimidine; dmbpy = 4,4'-dimethyl-2,2'-bipyridine; phen = 1,10-phenanthroline) were investigated for the first time. All compounds displayed potent in vitro antiproliferative activity against selected cancer cells. © The Royal Society of Chemistry 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21448489     DOI: 10.1039/c1cc11038a

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  3 in total

1.  In Vitro Anticancer Activity and in Vivo Biodistribution of Rhenium(I) Tricarbonyl Aqua Complexes.

Authors:  Kevin M Knopf; Brendan L Murphy; Samantha N MacMillan; Jeremy M Baskin; Martin P Barr; Eszter Boros; Justin J Wilson
Journal:  J Am Chem Soc       Date:  2017-09-26       Impact factor: 15.419

2.  Necroptosis-inducing rhenium(V) oxo complexes.

Authors:  Kogularamanan Suntharalingam; Samuel G Awuah; Peter M Bruno; Timothy C Johnstone; Fang Wang; Wei Lin; Yao-Rong Zheng; Julia E Page; Michael T Hemann; Stephen J Lippard
Journal:  J Am Chem Soc       Date:  2015-02-20       Impact factor: 15.419

3.  Deciphering the origin of giant magnetic anisotropy and fast quantum tunnelling in Rhenium(IV) single-molecule magnets.

Authors:  Saurabh Kumar Singh; Gopalan Rajaraman
Journal:  Nat Commun       Date:  2016-02-17       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.